| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC3620 |
| Trial ID | NCT06083883 |
| Disease | Synovial Sarcoma | Myxoid/Round Cell Liposarcoma |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-NK cell |
| Treatment | NY-ESO-1 TCR/IL-15 NK |
| HLA | HLA-A*02:01|HLA-A*02:05|HLA-A*02:06 |
| Phase | Phase1 |
| Recruitment status | Suspended |
| Title | Phase I/Ib Study of Adoptive NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Reactive Against the NY-ESO-1-specific Cord Blood-derived NK Cells (NY-ESO-1 TCR/IL-15 NK) in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma |
| Year | 2023 |
| Country | United States |
| Company sponsor | M.D. Anderson Cancer Center |
| Other ID(s) | 2023-0289|NCI-2023-08752 |
| Cohort 1 | |||||||||||
|
|||||||||||